BAM
MXCT icon

Bosun Asset Management’s MaxCyte MXCT Stock Holding History

Bosun Asset Management’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-19,386
Closed -$75.4K – 214
2024
Q3 		$75.4K Sell
19,386
-38,331
-66% -$162K 0.04% 182
2024
Q2 		$226K Buy
57,717
+20,467
+55% +$88K 0.13% 140
2024
Q1 		$156K Buy
+37,250
New +$175K 0.09% 178

Other funds holding MXCT

CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return
RGI
River Global Investors London, United Kingdom $515M AUM 24.86% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bosun Asset Management's MXCT Position: Q4 2024 in Review

Bosun Asset Management sold out of MaxCyte (MXCT) in Q4 2024, closing a stake of 19,386 shares — an estimated $75.4K sold.

Bosun Asset Management first reported a position in MXCT in Q1 2024 and held it in 3 quarters. The position peaked at $226K in Q2 2024. 119 funds tracked by Wall St. Rank hold MXCT as of Q4 2024.

  • Bosun Asset Management reported no remaining MaxCyte position as of Q4 2024 after selling out during the quarter.
  • Bosun Asset Management sold 19,386 MaxCyte shares in Q4 2024, an estimated $75.4K.
  • Bosun Asset Management first reported a position in MaxCyte in Q1 2024 and held it in 3 quarters.
  • Bosun Asset Management's MaxCyte position peaked at $226K in Q2 2024.
  • 119 funds tracked by Wall St. Rank held MaxCyte as of Q4 2024.

Based on Bosun Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.